Lecturer of Peking University China Center for Health Development Studies.

 

Research Fields:

Performance evaluation, data envelopment analysis (DEA) and DEA software  development, economic evaluation of health programs, drug policy

 

Education

(1) 2005.9- 2008.6: Center for Health Management and Policy, Shandong University, major in health economics, PhD;

(2) 2000.9-2003.6: Center for Health Management and Policy, Shandong University, major in social medicine and health management, Master of Medicine;

(3) 1992.9-1997.7: School of Public Health, Shandong Medical University，major in public health, Bachelor of Medicine.

 

Work Experiences

2010.12 – present: China Center for Health Development Studies, Peking University, lecturer

2008.12- 2010.12: School of Public Health, Peking University, postdoctoral work;

2008.7-2008.11: Center for Health Statistics Information, MOH;

2007.3-2008.2: the National Program Office, Global Fund China AIDS Program Round 3 (Beijing), program officer, responsible for planning, progress and financial reports, and prevention & intervention activities;

2003.7-2005.9: Center for Health Management and Policy, Shandong University, lecturer, scientific research;

1998.4-1999.9: Zhengdafurida Pharmaceutical Company (Jinan, Shandong), drug marketing;

1997.7-1998.3: Shandong Cardiovascular Hospital (Jinan, Shandong), doctor in the department of internal medicine.

 

Research Projects As the PI

Technical efficiency of HIV/AIDS Program based on DEA, funded by National Postdoctoral Scientific Fund, 2009.9-2010.11;

Access Barriers for Migrant Construction Workers to TB Care in China, funded by WHO-TDR, 2007.1-2007.12;

Assessment of resources for response to HIV/AIDS epidemic in China, funded by CHARTS (China-UK, China AIDS Roadmap Tactical Support Project), 2005.10-2006.10;

Evaluation and planning of applied research on HIV/AIDS in China, funded by CHARTS, 2005.3-2005.9;

Assessment of suitable health technology for rural China, funded by Ministry of Science and Technology/ Ministry of Health, 2005.1-2005.12;

WHO/TDR survey of TB diagnostic test prices, practices and preferences in 7 high burden countries: the survey in China, funded by WHO, 2003.9-2004.3;

China’s drug pricing policy reform: has it been effective in containing drug expenditures? Evidence from Shandong Province, funded by WHO-Alliance for Health Policy and Systems Research, 2002.2-2003.4.

 

Publications

In international journals:

Cheng G., Qian Z., Guo Y.,Overcoming the infeasibility of super-efficiency DEA model: a model with generalized orientation. Proceedings of the 8^th International DEA Conference, Lebanon, 2010.

Guo, Y., Shibuya, K., Cheng, G., Rao, K.Q., Lee, L., and Tang, S.L., Tracking China's health reform. Lancet. 2010, 375(9720): 1056-1058.

Cheng, G., Tolhurst, R., Li, R.Z., Meng, Q.Y., and Tang, S., Factors affecting delays in tuberculosis diagnosis in rural China: a case study in four counties in Shandong Province. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2005, 99(5): 355-362.

Meng, Q.Y., Cheng, G., Silver, L., Sun, X.J., Rehnberg, C., and Tomson, G., The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals. Health Policy and Planning. 2005, 20(3): 185-196.

Meng, Q.Y., Li, R.Z., Cheng, G., and Blas, E., Provision and financial burden of TB services in a financially decentralized system: a case study from Shandong, China. International Journal of Health Planning and Management. 2004, 19: S45-S62.

 

In Chinese journals (First author only):

Cheng G. Commentary on “Interventions to improve outpatient referrals from primary care to secondary care”. Chinese Journal of Evidence-based Medicine， 2010;10(1):4。

Cheng G, Qian Z, Hu J. Longitudinal analysis of technical efficiency of voluntary counseling and testing of HIV in China. Journal of Peking University, 2009; 41(2):135-140

Cheng G.. Commentary on “Pharmaceutical policies effects of reference pricing, other pricing and purchasing policies”. Chinese Journal of Evidence-based Medicine， 2008;8(12):1033

Cheng G, Qian Z, Meng Q. Application of Data Envelopment Analysis to Management by Objectives in Public Health Programs. Chinese Health Economics 2008;27(3):33-36

Cheng G, Yang L, Pan X, Meng Q. Analysis of regional allocation of financing resources for HIV/AIDS control in China. Chinese Heath Resources 2007; 10(4):199-200

Cheng G, Xu B, Pan X, Meng Q. Analysis of financing sources for HIV/AIDS control in China. Chinese Health Economics 2007;26(6):48-49

Cheng G, Wang C, Meng Q. Application of an analytic hierarchy process for developing the indicator system of health technology comprehensive assessment .Chinese Health Resources 2005; (5): 231-232;

Cheng G, Zhou G, Li R, Meng Q Analysis of medical cost of TB patients in rural Shandong Province. Chinese Rural Health Management 2004; 24(5): 21-23

Cheng G, Zhou G, Li R, Meng Q Weibull parameteric model of TB patients’ delays in seeking health care and diagnosis. Chinese Journal of Hospital Administration 2004; 20(6): 365-367;

 

Other Research Products

DataEasy: A professional software for data entry(http://www.maxdea.cn/download/DataEasy.zip);

MaxDEA: A professional software for data envelopment analysis (http://